Skip to main content
Livermore
Livermore
ZHEN

Creative Planning

SEC CIK
0001540235
Latest filing
Aug 13, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by Creative Planning, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q2 2026)
153,161
Value
$8.76M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BMRN by Creative Planning, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026153,161$8.76M<0.1%+40,061+35.4%AddedHolders
Q1 2026113,100$6.39M<0.1%+45,259+66.7%AddedHolders
Q4 202567,841$4.03M<0.1%+33,476+97.4%AddedHolders
Q3 202534,365$1.86M<0.1%+11,405+49.7%AddedHolders
Q2 202522,960$1.26M<0.1%−3,010−11.6%ReducedHolders
Q1 202525,970$1.84M<0.1%−7,791−23.1%ReducedHolders
Q4 202433,761$2.22M<0.1%+19,461+136.1%AddedHolders
Q3 202414,300$1.01M<0.1%+2,475+20.9%AddedHolders
Q2 202411,825$973.6K<0.1%+524+4.6%AddedHolders
Q1 202411,301$987.0K<0.1%−10.0%ReducedHolders
Q4 202311,302$1.09M<0.1%+2,736+31.9%AddedHolders
Q3 20238,566$757.9K<0.1%+507+6.3%AddedHolders
Q2 20238,059$698.6K<0.1%+1,074+15.4%AddedHolders
Q1 20236,985$679.2K<0.1%+163+2.4%AddedHolders
Q4 20226,822$706.0K<0.1%+532+8.5%AddedHolders
Q3 20226,290$533.0K<0.1%+53+0.8%AddedHolders
Q2 20226,237$517.0K<0.1%+2,744+78.6%AddedHolders
Q1 20223,493$269.0K<0.1%−1,302−27.2%ReducedHolders
Q4 20214,795$424.0K<0.1%+21+0.4%AddedHolders
Q3 20214,774$369.0K<0.1%+251+5.5%AddedHolders
Q2 20214,523$377.0K<0.1%−438−8.8%ReducedHolders
Q1 20214,961$375.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.